Millennium Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Millennium Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-560,358	Closed	-$26M	–	6825
2023 Q2	$26M	Buy	560,358 +288,784	+106%	+$10M	0.01%	1167
2023 Q1	$7.78M	Buy	271,574 +61,262	+29%	+$1.81M	﹤0.01%	2206
2022 Q4	$6.56M	Buy	210,312 +33,811	+19%	+$1.1M	﹤0.01%	2562
2022 Q3	$3.58M	Sell	176,501 -3,119	-2%	-$56.8K	﹤0.01%	3211
2022 Q2	$2.79M	Sell	179,620 -101,776	-36%	-$1.75M	﹤0.01%	3374
2022 Q1	$5.38M	Buy	281,396 +218,903	+350%	+$3.91M	﹤0.01%	2850
2021 Q4	$1.58M	Sell	62,493 -304,063	-83%	-$8.91M	﹤0.01%	3978
2021 Q3	$12M	Buy	+366,556	New	+$12.5M	0.01%	1832

Millennium Management's DICE Position: Q3 2023 in Review

Millennium Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 560,358 shares — an estimated $26M sold.

Millennium Management first reported a position in DICE in Q3 2021 and held it in 8 quarters. The position peaked at $26M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Millennium Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Millennium Management sold 560,358 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $26M.
Millennium Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Millennium Management's DICE Therapeutics, Inc. Common Stock position peaked at $26M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.